- Home
- PSNYW vs TNYA Comparison
PSNYW vs TNYA Comparison
Compare PSNYW & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNYW | TNYA |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Sweden | United States |
| Employees | 2547 | N/A |
| Industry | Auto Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.4M | 234.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PSNYW | TNYA |
|---|---|---|
| Price | $6.23 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 43.4K | ★ 7.5M |
| Earning Date | 03-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,034,261,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $79.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.09 | $0.36 |
| 52 Week High | $0.61 | $2.35 |
Technical Indicators
Market Signals| Indicator | PSNYW | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 74.17 | 32.00 |
| Support Level | $5.07 | $0.66 |
| Resistance Level | $7.50 | $0.76 |
| Average True Range (ATR) | 0.94 | 0.09 |
| MACD | 0.28 | -0.02 |
| Stochastic Oscillator | 78.17 | 6.76 |
Price Performance
Historical ComparisonAbout PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.